Triple combination of pegylated interferon alpha 2b, ribavirin and amantadine for treatment of chronic hepatitis

被引：0
|
作者：
Younossi, ZM
McCullough, AJ
Barnes, DS
Post, A
Ong, JP
Mullen, KD
Carey, WD
O'Shea, R
Levinthal, G
Gramlich, T
Martin, LM
Bringman, D
Tavill, A
Ferguson, R
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)83944-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A781 / A781
页数：1
相关论文
共 50 条
  • [1] Pegylated Interferon α-2b, Ribavirin and Amantadine for Chronic Hepatitis C
    Zobair M. Younossi
    Arthur C. McCullough
    David S. Barnes
    Anthony Post
    Janus P. Ong
    Robert O’shea
    Lisa M. Martin
    Diane Bringman
    Denise Farmer
    Gavin Levinthal
    Kevin D. Mullen
    William D. Carey
    Anthony S. Tavill
    Roy Ferguson
    Terry Gramlich
    Digestive Diseases and Sciences, 2005, 50 : 970 - 975
  • [2] Pegylated interferon α-2b, ribavirin and amantadine for chronic hepatitis C
    Younossi, ZM
    McCullough, A
    Barnes, D
    Post, A
    Ong, J
    O'Shea, R
    Martin, LM
    Bringman, D
    Farmer, D
    Levinthal, G
    Mullen, KD
    Carey, WD
    Tavill, AS
    Ferguson, R
    Gramlich, T
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (05) : 970 - 975
  • [3] Triple combination of interferon alpha-2b, ribavirin, and amantadine for treatment of chronic hepatitis C
    Younossi, ZM
    Mullen, KD
    Hodnick, S
    Barnes, DS
    Carey, WD
    McCullough, AC
    Easley, K
    Gramlich, T
    Liebermann, BY
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 36 (05) : 427 - 430
  • [4] Cost effectiveness of pegylated interferon alpha 2b and ribavirin combination in chronic hepatitis C
    Poynard, T
    GUT, 2003, 52 (10) : 1532 - 1532
  • [5] Interferon Alpha 2b in Combination with Ribavirin as a Treatment for Chronic Hepatitis C
    Mandokhel, Sherbet Khan
    Aziz-U-Rehman
    Khan, Mohammad Saleem
    Azeemullah
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2011, 5 (01): : 168 - 171
  • [6] Combination Therapy with Interferon-α2b, Ribavirin, and Amantadine in Chronic Hepatitis C Nonresponders to Interferon and Ribavirin
    Paul J. Thuluvath
    Hemant Pande
    Joyce Maygers
    Digestive Diseases and Sciences, 2003, 48 : 594 - 597
  • [7] Combination therapy with interferon-α2b, ribavirin, and amantadine in chronic hepatitis C nonresponders to interferon and ribavirin
    Thuluvath, PJ
    Pande, H
    Maygers, J
    DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (03) : 594 - 597
  • [8] Triple combination of interferon A-2b, ribavirin, and amantadine for treatment of chronic hepatitis C.
    Younossi, ZM
    Mullen, KD
    Hodnick, S
    McCormick, M
    Bringman, D
    Barnes, DS
    Carey, WD
    McCullough, AJ
    Easley, K
    Yen-Lieberman, B
    GASTROENTEROLOGY, 2000, 118 (04) : A1501 - A1501
  • [9] A randomized prospective clinical trial comparing pegylated interferon alpha 2a/ribavirin versus pegylated interferon alpha 2b/ribavirin in the treatment of Chronic Hepatitis C
    Sinha, S
    Gulur, P
    Patel, V
    Hage-Nassar, G
    Tenner, S
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S77 - S78
  • [10] Pegylated interferon alpha-2b monotherapy and in combination with ribavirin in chronic hepatitis delta
    Niro, G. A.
    Ciancio, A.
    Gaeta, G. B.
    Marrone, A.
    Olivero, A.
    Stanzione, M.
    Stornaiuolo, G.
    Smedile, A.
    Andriulli, A.
    Rizzetto, M.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S188 - S188
12345